Innovating
Health Solutions
with Exosome-based
Nano Formulation
We initiated this startup to develop advance technologies using Stem Cells secreting exosomes for formulating innovative healthcare products and to treat various disease conditions.
We aim to develop products at affordable prices and off-the-shelf availability.
About TCIPL
-
Tech Cell Innovations (TCIPL) is an early-stage startup based in Delhi, founded in 2022, dedicated to pioneering research in stem cells and leveraging the potential of exosomes for biomedical innovation.
-
Our portfolio encompasses advanced therapies and next-generation treatments aimed at making a substantial impact on overall health and well-being by harnessing cutting-edge biomedical applications.
-
Our multidisciplinary team, comprising professionals from both Research & Development and Clinical fields, collaborates synergistically to develop robust solutions that align with clinical contexts and cater to the specific requirements of patients and researchers.
Sources & Formulation
Tech Cell Innovations presents a revolutionary approach to healing through its advanced products derived from extensive research and cutting-edge technology.
Our key offerings are centered around the healing of Skin Wound Injuries by harnessing the potential of exosomes from umbilical-derived Mesenchymal Stem Cells and Biomaterial.
Exosome-based Products
Utilizing HLA-class II negative exosomes derived from umbilical-cord Mesenchymal Stem Cells, our products ensure enhanced compatibility & effectiveness.
Stem Cell Sources
Our products derive from varied sources such as bone marrow, placenta, fat, and teeth, ensuring versatility and potency.
Formulation Varieties
Available in multiple forms including Powder, Spray, and Solution, catering to diverse application needs.
USP of Tech Cell Innovation
Our Team
The Trailblazing Team
